Effect of DT-TX 30, a Combined Thromboxane Synthase Inhibitor and Thromboxane Receptor Antagonist, on Retinal Vascularity in Experimental Diabetes Mellitus - A novel device for assessing platelet behavior in blood

Author： De La Cruz J.P.   Moreno A.   Ruiz-Ruiz M.I.   De La Cuesta F.S.  

Publisher： Elsevier

E-ISSN： 1879-2472|97|3|125-131

ISSN： 0049-3848

Source： Thrombosis Research, Vol.97, Iss.3, 2000-02, pp. : 125-131

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Brief communication the combination of thrombin inhibitor and thromboxane synthase inhibitor on experimental thrombosis and bleeding

By Kawai H.   Tamao Y.  

Thrombosis Research, Vol. 80, Iss. 5, 1995-12 ,pp. : 429-434

Elsevier

Access to resources Recommend Favorite

Beneficial effect of CV-4151 (Isbogrel), a thromboxane A 2 synthase inhibitor, in a rat middle cerebral artery thrombosis model

By Imura Y.   Kiyota Y.   Nagai Y.   Terashita Z.-i.   Nishikawa K.  

Thrombosis Research, Vol. 79, Iss. 1, 1995-07 ,pp. : 95-107

Elsevier

Access to resources Recommend Favorite

Effect of the Thromboxane Prostaglandin Receptor Antagonist Terutroban on Arterial Thrombogenesis after Repeated Administration in Patients Treated for the Prevention of Ischemic Stroke

By  

Cerebrovascular Diseases, Vol. 28, Iss. 5, 2009-09 ,pp. : 505-513

Karger

Access to resources Recommend Favorite

Passive smoking and platelet thromboxane

By Karanikas G.   Schmid P.   Kritz H.   Pirich C.   Stamatopoulos Y.   Peskar B.A.   Sinzinger h.  

Thrombosis Research, Vol. 81, Iss. 4, 1996-02 ,pp. : 451-460

Elsevier

Access to resources Recommend Favorite

Antiplatelet and Anticoagulant Effects of ''HN-11 500,'' a Selective Thromboxane Receptor Antagonist

By Schenk J.F.   Radziwon P.   Fellier H.   Breddin H.K.  

Thrombosis Research, Vol. 103, Iss. 2, 2001-07 ,pp. : 79-91

Elsevier

Access to resources Recommend Favorite